Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease (Q34774184)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12162917

retrieved

4 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12162917

retrieved

4 August 2017

main subject

adaptive radiation therapy

0 references

author name string

Joachim Yahalom

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12162917

retrieved

4 August 2017

publication date

1 September 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12162917

retrieved

4 August 2017

published in

Current Oncology Reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12162917

retrieved

4 August 2017

volume

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12162917

retrieved

4 August 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12162917

retrieved

4 August 2017

page(s)

415-423

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12162917

retrieved

4 August 2017

cites work

The management of Hodgkin's disease: half a century of change. The Kaplan Memorial Lecture

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11912-002-0036-9

retrieved

21 January 2018

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11912-002-0036-9

retrieved

21 January 2018

The involved field is back: issues in delineating the radiation field in Hodgkin's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11912-002-0036-9

retrieved

21 January 2018

Prognostic factors for patients with Hodgkin disease in first relapse

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study of Hodgkin's disease treated by irradiation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radical radiotherapy as salvage treatment for relapse of Hodgkin's disease initially treated by chemotherapy alone: prognostic significance of the disease-free interval.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is the value of autologous bone marrow transplantation in the treatment of relapsed or resistant Hodgkin's disease?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mantle irradiation alone for clinical stage I-II Hodgkin's disease: long-term follow-up and analysis of prognostic factors in 261 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of Relapsed and Refractory Hodgkin's Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Radical Radiotherapy of Regionally Localized Hodgkin's Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer and other second neoplasms after childhood Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival in advanced Hodgkin's disease with the use of combined modality therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A decade of combination chemotherapy of advanced Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage radiotherapy for hodgkin's disease following chemotherapy failure

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involved field radiation therapy for Hodgkin's disease autologous bone marrow transplantation regimens

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy of Advanced Hodgkin's Disease With Curative Intent

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors affecting late mortality from heart disease after treatment of Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is the role for adjuvant radiation therapy in advanced Hodgkin's disease?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The case for adjuvant radiation therapy in advanced Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do not miss a second (and possibly last) chance to cure Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrating radiotherapy into bone marrow transplantation programs for Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hodgkin's disease: the right dose

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of high-dose and low-dose radiation with and without chemotherapy for children with Hodgkin's disease: an analysis of the experience at the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hodgkin's disease--the role of radiation therapy in advanced disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of the stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group pilot study E1492

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a prospective trial of mantle irradiation alone for selected patients with early-stage Hodgkin's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation and radiotherapeutic management of Hodgkin's disease and the malignant lymphomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymph

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12162917

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11912-002-0036-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12162917

retrieved

4 August 2017

Dimensions Publication ID

1009061742

0 references

PubMed publication ID

12162917

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12162917

retrieved

4 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34774184&oldid=2197027111"